Rebalix
Logo XtrackersXtrackers · sheet of 10 September 2026
ETF sheet · official issuer and register data

Xtrackers Msci World Health Care UCITS ETF 1c

IE00BM67HK77 · IE00BM67HK77 · USD · domicile Ireland
Equity · Global · Health careSFDR art. 6 (inferred)
Index tracked: MSCI WORLD HEALTH CARE TRN INDEX (USD)
TER
0.25%+ trans. 0.01%
Fund size
3.3 bn EUR
Tracking difference
−0.03%3-year avg
🇮🇹 tax rate
white list not published
Replication
Physical
Income
Accumulating
Launch 4 Mar 2016 · costs from the KID as of 2 Sept 2026 · 125 securities held · 10 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The fund is passively managed. INVESTMENT OBJECTIVE: The aim is for your investment to reflect the performance of the MSCI World Health Care Total Return Net index (index) which is designed to reflect the performance of the listed shares of certain companies from various developed countries. DESCRIPTION OF INDEX: The shares are issued by companies in the health care sector. A company’s weighting in the index depends on its relative size based on the combined value of a company’s readily available shares as compared to other companies. INDEX…

Performance since series start (in euro) — base 100

22 Nov 20108 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
20112014201720202023202664293612
High 642 (19 Aug 2026) · low 93 (10 Aug 2011) · last 612. Past performance is not indicative of future results.

Returns in euro

1 year+17.1%
3 years+16.1%
5 years+23.9%
10 years+121.5%
Since series start+511.7%

Risk · 1 / 3 / 5 years

Volatility (ann.)14.72%12.97%13.45%
Max drawdown−10.51%−17.67%−17.67%
Sharpe0.940.390.17
Sortino1.540.560.25
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IE00BM67HK77 · IE00BM67HK771
RebalixIE00BM67HK77 · IE00BM67HK77 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+14.83%+14.83%+0.00%
2024+1.08%+1.13%−0.05%
2023+3.73%+3.76%−0.03%
2022−5.45%−5.41%−0.04%
2021+19.68%+19.80%−0.12%

Holdings

Portfolio as declared by the issuer · 2 Sept 2026 · 125 securities · top-10 weight = 47.6%
Top holdingsWeight
ELI LILLY10.9%
JOHNSON & JOHNSON7.6%
ABBVIE5.4%
MERCK & CO INC4.3%
UNITEDHEALTH GROUP INC4.2%
ROCHE PS PAR AG3.5%
NOVARTIS AG3.5%
ASTRAZENECA PLC2.9%
AMGEN INC2.8%
THERMO FISHER SCIENTIFIC INC2.6%
Countries (% of fund)
United States74.0%Switzerland9.8%United Kingdom4.2%Japan3.4%Denmark2.1%
Sectors (% of fund)
Pharmaceuticals46.8%Biotechnology17.6%Health Care Equipment12.2%Life Sciences Tools & Serv…7.5%Managed Health Care6.2%

Listing venues

ESMA register (FIRDS) and official exchange lists
XDWH · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
· Nasdaq Stockholm
+ 21 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · etf.dws.com/download/asset/b604af05-9aaf-45af-afad-c918d6b4bef4
Factsheet · etf.dws.com/download/asset/27c2fc51-356d-48b2-b8e7-9a92c7a0f030
Prospectus · etf.dws.com/download/asset/25f159fa-a123-4a77-9751-682976c15095
The live sheet, always up to date
rebalix.com/en/etf/IE00BM67HK77
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · IE00BM67HK77 · IE00BM67HK772